カテゴリ： 世界, 医療/バイオ, Market Monitor Global

カルシウムチャネル拮抗薬のグローバル市場展望 2023年-2029年：ジヒドロピリジン、非ジヒドロピリジン

■ 英語タイトル：Calcium Channel Antagonist Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14253）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14253
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：134
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[カルシウムチャネル拮抗薬のグローバル市場展望 2023年-2029年：ジヒドロピリジン、非ジヒドロピリジン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のカルシウムチャネル拮抗薬市場規模と予測を収録しています。・世界のカルシウムチャネル拮抗薬市場：売上、2018年-2023年、2024年-2029年
・世界のカルシウムチャネル拮抗薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のカルシウムチャネル拮抗薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ジヒドロピリジン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

カルシウムチャネル拮抗薬のグローバル主要企業は、Pfizer、 Aventis、 Searle、 Bayer、 AstraZeneca、 Knoll Pharmaceuticals、 Wyeth-Ayerst、 AstraZeneca、 Novartis、 Sanofi、 Kyowa Kirin、 Daiichi Sankyo、 Shi Huida、 Yangtze River、 Chengdu Bate、 Jiangsu Hengruiなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、カルシウムチャネル拮抗薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のカルシウムチャネル拮抗薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のカルシウムチャネル拮抗薬市場：タイプ別市場シェア、2022年
・ジヒドロピリジン、非ジヒドロピリジン

世界のカルシウムチャネル拮抗薬市場：用途別、2018年-2023年、2024年-2029年
世界のカルシウムチャネル拮抗薬市場：用途別市場シェア、2022年
・病院、診療所、その他

世界のカルシウムチャネル拮抗薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のカルシウムチャネル拮抗薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるカルシウムチャネル拮抗薬のグローバル売上、2018年-2023年
・主要企業におけるカルシウムチャネル拮抗薬のグローバル売上シェア、2022年
・主要企業におけるカルシウムチャネル拮抗薬のグローバル販売量、2018年-2023年
・主要企業におけるカルシウムチャネル拮抗薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Pfizer、 Aventis、 Searle、 Bayer、 AstraZeneca、 Knoll Pharmaceuticals、 Wyeth-Ayerst、 AstraZeneca、 Novartis、 Sanofi、 Kyowa Kirin、 Daiichi Sankyo、 Shi Huida、 Yangtze River、 Chengdu Bate、 Jiangsu Hengrui

*************************************************************

・調査・分析レポートの概要
カルシウムチャネル拮抗薬市場の定義
市場セグメント
世界のカルシウムチャネル拮抗薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のカルシウムチャネル拮抗薬市場規模
世界のカルシウムチャネル拮抗薬市場規模：2022年 VS 2029年
世界のカルシウムチャネル拮抗薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのカルシウムチャネル拮抗薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のカルシウムチャネル拮抗薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ジヒドロピリジン、非ジヒドロピリジン
カルシウムチャネル拮抗薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
カルシウムチャネル拮抗薬の用途別グローバル売上・予測

・地域別市場分析
地域別カルシウムチャネル拮抗薬市場規模 2022年と2029年
地域別カルシウムチャネル拮抗薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer、 Aventis、 Searle、 Bayer、 AstraZeneca、 Knoll Pharmaceuticals、 Wyeth-Ayerst、 AstraZeneca、 Novartis、 Sanofi、 Kyowa Kirin、 Daiichi Sankyo、 Shi Huida、 Yangtze River、 Chengdu Bate、 Jiangsu Hengrui
...

This research report provides a comprehensive analysis of the Calcium Channel Antagonist market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Calcium Channel Antagonist market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Calcium Channel Antagonist, challenges faced by the industry, and potential opportunities for market players.
The global Calcium Channel Antagonist market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Calcium Channel Antagonist market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Calcium Channel Antagonist market. Additionally, the growing consumer demand present avenues for market expansion.
The global Calcium Channel Antagonist market was valued at US$ 1367.6 million in 2022 and is projected to reach US$ 1835.2 million by 2029, at a CAGR of 4.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Calcium Channel Antagonist market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Calcium Channel Antagonist market.
Market Overview: The report provides a comprehensive overview of the Calcium Channel Antagonist market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Dihydropyridines, Non-dihydropyridines), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Calcium Channel Antagonist market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Calcium Channel Antagonist market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Calcium Channel Antagonist market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Calcium Channel Antagonist market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Calcium Channel Antagonist market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Calcium Channel Antagonist market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Calcium Channel Antagonist, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Calcium Channel Antagonist market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Calcium Channel Antagonist market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Dihydropyridines
Non-dihydropyridines
Market segment by Application
Hospital
Clinic
Other
Global Calcium Channel Antagonist Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi
Kyowa Kirin
Daiichi Sankyo
Shi Huida
Yangtze River
Chengdu Bate
Jiangsu Hengrui
Outline of Major Chapters:
Chapter 1: Introduces the definition of Calcium Channel Antagonist, market overview.
Chapter 2: Global Calcium Channel Antagonist market size in revenue and volume.
Chapter 3: Detailed analysis of Calcium Channel Antagonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Calcium Channel Antagonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Calcium Channel Antagonist capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Calcium Channel Antagonist Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Calcium Channel Antagonist Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Calcium Channel Antagonist Overall Market Size
2.1 Global Calcium Channel Antagonist Market Size: 2022 VS 2029
2.2 Global Calcium Channel Antagonist Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Calcium Channel Antagonist Sales: 2018-2029
3 Company Landscape
3.1 Top Calcium Channel Antagonist Players in Global Market
3.2 Top Global Calcium Channel Antagonist Companies Ranked by Revenue
3.3 Global Calcium Channel Antagonist Revenue by Companies
3.4 Global Calcium Channel Antagonist Sales by Companies
3.5 Global Calcium Channel Antagonist Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Calcium Channel Antagonist Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Calcium Channel Antagonist Product Type
3.8 Tier 1, Tier 2 and Tier 3 Calcium Channel Antagonist Players in Global Market
3.8.1 List of Global Tier 1 Calcium Channel Antagonist Companies
3.8.2 List of Global Tier 2 and Tier 3 Calcium Channel Antagonist Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Calcium Channel Antagonist Market Size Markets, 2022 & 2029
4.1.2 Dihydropyridines
4.1.3 Non-dihydropyridines
4.2 By Type – Global Calcium Channel Antagonist Revenue & Forecasts
4.2.1 By Type – Global Calcium Channel Antagonist Revenue, 2018-2023
4.2.2 By Type – Global Calcium Channel Antagonist Revenue, 2024-2029
4.2.3 By Type – Global Calcium Channel Antagonist Revenue Market Share, 2018-2029
4.3 By Type – Global Calcium Channel Antagonist Sales & Forecasts
4.3.1 By Type – Global Calcium Channel Antagonist Sales, 2018-2023
4.3.2 By Type – Global Calcium Channel Antagonist Sales, 2024-2029
4.3.3 By Type – Global Calcium Channel Antagonist Sales Market Share, 2018-2029
4.4 By Type – Global Calcium Channel Antagonist Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Calcium Channel Antagonist Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Calcium Channel Antagonist Revenue & Forecasts
5.2.1 By Application – Global Calcium Channel Antagonist Revenue, 2018-2023
5.2.2 By Application – Global Calcium Channel Antagonist Revenue, 2024-2029
5.2.3 By Application – Global Calcium Channel Antagonist Revenue Market Share, 2018-2029
5.3 By Application – Global Calcium Channel Antagonist Sales & Forecasts
5.3.1 By Application – Global Calcium Channel Antagonist Sales, 2018-2023
5.3.2 By Application – Global Calcium Channel Antagonist Sales, 2024-2029
5.3.3 By Application – Global Calcium Channel Antagonist Sales Market Share, 2018-2029
5.4 By Application – Global Calcium Channel Antagonist Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Calcium Channel Antagonist Market Size, 2022 & 2029
6.2 By Region – Global Calcium Channel Antagonist Revenue & Forecasts
6.2.1 By Region – Global Calcium Channel Antagonist Revenue, 2018-2023
6.2.2 By Region – Global Calcium Channel Antagonist Revenue, 2024-2029
6.2.3 By Region – Global Calcium Channel Antagonist Revenue Market Share, 2018-2029
6.3 By Region – Global Calcium Channel Antagonist Sales & Forecasts
6.3.1 By Region – Global Calcium Channel Antagonist Sales, 2018-2023
6.3.2 By Region – Global Calcium Channel Antagonist Sales, 2024-2029
6.3.3 By Region – Global Calcium Channel Antagonist Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Calcium Channel Antagonist Revenue, 2018-2029
6.4.2 By Country – North America Calcium Channel Antagonist Sales, 2018-2029
6.4.3 US Calcium Channel Antagonist Market Size, 2018-2029
6.4.4 Canada Calcium Channel Antagonist Market Size, 2018-2029
6.4.5 Mexico Calcium Channel Antagonist Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Calcium Channel Antagonist Revenue, 2018-2029
6.5.2 By Country – Europe Calcium Channel Antagonist Sales, 2018-2029
6.5.3 Germany Calcium Channel Antagonist Market Size, 2018-2029
6.5.4 France Calcium Channel Antagonist Market Size, 2018-2029
6.5.5 U.K. Calcium Channel Antagonist Market Size, 2018-2029
6.5.6 Italy Calcium Channel Antagonist Market Size, 2018-2029
6.5.7 Russia Calcium Channel Antagonist Market Size, 2018-2029
6.5.8 Nordic Countries Calcium Channel Antagonist Market Size, 2018-2029
6.5.9 Benelux Calcium Channel Antagonist Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Calcium Channel Antagonist Revenue, 2018-2029
6.6.2 By Region – Asia Calcium Channel Antagonist Sales, 2018-2029
6.6.3 China Calcium Channel Antagonist Market Size, 2018-2029
6.6.4 Japan Calcium Channel Antagonist Market Size, 2018-2029
6.6.5 South Korea Calcium Channel Antagonist Market Size, 2018-2029
6.6.6 Southeast Asia Calcium Channel Antagonist Market Size, 2018-2029
6.6.7 India Calcium Channel Antagonist Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Calcium Channel Antagonist Revenue, 2018-2029
6.7.2 By Country – South America Calcium Channel Antagonist Sales, 2018-2029
6.7.3 Brazil Calcium Channel Antagonist Market Size, 2018-2029
6.7.4 Argentina Calcium Channel Antagonist Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Calcium Channel Antagonist Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Calcium Channel Antagonist Sales, 2018-2029
6.8.3 Turkey Calcium Channel Antagonist Market Size, 2018-2029
6.8.4 Israel Calcium Channel Antagonist Market Size, 2018-2029
6.8.5 Saudi Arabia Calcium Channel Antagonist Market Size, 2018-2029
6.8.6 UAE Calcium Channel Antagonist Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Calcium Channel Antagonist Major Product Offerings
7.1.4 Pfizer Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Aventis
7.2.1 Aventis Company Summary
7.2.2 Aventis Business Overview
7.2.3 Aventis Calcium Channel Antagonist Major Product Offerings
7.2.4 Aventis Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.2.5 Aventis Key News & Latest Developments
7.3 Searle
7.3.1 Searle Company Summary
7.3.2 Searle Business Overview
7.3.3 Searle Calcium Channel Antagonist Major Product Offerings
7.3.4 Searle Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.3.5 Searle Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Calcium Channel Antagonist Major Product Offerings
7.4.4 Bayer Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Calcium Channel Antagonist Major Product Offerings
7.5.4 AstraZeneca Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Knoll Pharmaceuticals
7.6.1 Knoll Pharmaceuticals Company Summary
7.6.2 Knoll Pharmaceuticals Business Overview
7.6.3 Knoll Pharmaceuticals Calcium Channel Antagonist Major Product Offerings
7.6.4 Knoll Pharmaceuticals Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.6.5 Knoll Pharmaceuticals Key News & Latest Developments
7.7 Wyeth-Ayerst
7.7.1 Wyeth-Ayerst Company Summary
7.7.2 Wyeth-Ayerst Business Overview
7.7.3 Wyeth-Ayerst Calcium Channel Antagonist Major Product Offerings
7.7.4 Wyeth-Ayerst Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.7.5 Wyeth-Ayerst Key News & Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Calcium Channel Antagonist Major Product Offerings
7.8.4 AstraZeneca Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.8.5 AstraZeneca Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Calcium Channel Antagonist Major Product Offerings
7.9.4 Novartis Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Calcium Channel Antagonist Major Product Offerings
7.10.4 Sanofi Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
7.11 Kyowa Kirin
7.11.1 Kyowa Kirin Company Summary
7.11.2 Kyowa Kirin Business Overview
7.11.3 Kyowa Kirin Calcium Channel Antagonist Major Product Offerings
7.11.4 Kyowa Kirin Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.11.5 Kyowa Kirin Key News & Latest Developments
7.12 Daiichi Sankyo
7.12.1 Daiichi Sankyo Company Summary
7.12.2 Daiichi Sankyo Business Overview
7.12.3 Daiichi Sankyo Calcium Channel Antagonist Major Product Offerings
7.12.4 Daiichi Sankyo Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.12.5 Daiichi Sankyo Key News & Latest Developments
7.13 Shi Huida
7.13.1 Shi Huida Company Summary
7.13.2 Shi Huida Business Overview
7.13.3 Shi Huida Calcium Channel Antagonist Major Product Offerings
7.13.4 Shi Huida Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.13.5 Shi Huida Key News & Latest Developments
7.14 Yangtze River
7.14.1 Yangtze River Company Summary
7.14.2 Yangtze River Business Overview
7.14.3 Yangtze River Calcium Channel Antagonist Major Product Offerings
7.14.4 Yangtze River Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.14.5 Yangtze River Key News & Latest Developments
7.15 Chengdu Bate
7.15.1 Chengdu Bate Company Summary
7.15.2 Chengdu Bate Business Overview
7.15.3 Chengdu Bate Calcium Channel Antagonist Major Product Offerings
7.15.4 Chengdu Bate Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.15.5 Chengdu Bate Key News & Latest Developments
7.16 Jiangsu Hengrui
7.16.1 Jiangsu Hengrui Company Summary
7.16.2 Jiangsu Hengrui Business Overview
7.16.3 Jiangsu Hengrui Calcium Channel Antagonist Major Product Offerings
7.16.4 Jiangsu Hengrui Calcium Channel Antagonist Sales and Revenue in Global (2018-2023)
7.16.5 Jiangsu Hengrui Key News & Latest Developments
8 Global Calcium Channel Antagonist Production Capacity, Analysis
8.1 Global Calcium Channel Antagonist Production Capacity, 2018-2029
8.2 Calcium Channel Antagonist Production Capacity of Key Manufacturers in Global Market
8.3 Global Calcium Channel Antagonist Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Calcium Channel Antagonist Supply Chain Analysis
10.1 Calcium Channel Antagonist Industry Value Chain
10.2 Calcium Channel Antagonist Upstream Market
10.3 Calcium Channel Antagonist Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Calcium Channel Antagonist Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Calcium Channel Antagonist in Global Market
Table 2. Top Calcium Channel Antagonist Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Calcium Channel Antagonist Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Calcium Channel Antagonist Revenue Share by Companies, 2018-2023
Table 5. Global Calcium Channel Antagonist Sales by Companies, (K Units), 2018-2023
Table 6. Global Calcium Channel Antagonist Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Calcium Channel Antagonist Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Calcium Channel Antagonist Product Type
Table 9. List of Global Tier 1 Calcium Channel Antagonist Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Calcium Channel Antagonist Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Calcium Channel Antagonist Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Calcium Channel Antagonist Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Calcium Channel Antagonist Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Calcium Channel Antagonist Sales (K Units), 2018-2023
Table 15. By Type - Global Calcium Channel Antagonist Sales (K Units), 2024-2029
Table 16. By Application – Global Calcium Channel Antagonist Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Calcium Channel Antagonist Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Calcium Channel Antagonist Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Calcium Channel Antagonist Sales (K Units), 2018-2023
Table 20. By Application - Global Calcium Channel Antagonist Sales (K Units), 2024-2029
Table 21. By Region – Global Calcium Channel Antagonist Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Calcium Channel Antagonist Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Calcium Channel Antagonist Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Calcium Channel Antagonist Sales (K Units), 2018-2023
Table 25. By Region - Global Calcium Channel Antagonist Sales (K Units), 2024-2029
Table 26. By Country - North America Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Calcium Channel Antagonist Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Calcium Channel Antagonist Sales, (K Units), 2018-2023
Table 29. By Country - North America Calcium Channel Antagonist Sales, (K Units), 2024-2029
Table 30. By Country - Europe Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Calcium Channel Antagonist Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Calcium Channel Antagonist Sales, (K Units), 2018-2023
Table 33. By Country - Europe Calcium Channel Antagonist Sales, (K Units), 2024-2029
Table 34. By Region - Asia Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Calcium Channel Antagonist Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Calcium Channel Antagonist Sales, (K Units), 2018-2023
Table 37. By Region - Asia Calcium Channel Antagonist Sales, (K Units), 2024-2029
Table 38. By Country - South America Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Calcium Channel Antagonist Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Calcium Channel Antagonist Sales, (K Units), 2018-2023
Table 41. By Country - South America Calcium Channel Antagonist Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Calcium Channel Antagonist Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Calcium Channel Antagonist Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Calcium Channel Antagonist Sales, (K Units), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Calcium Channel Antagonist Product Offerings
Table 48. Pfizer Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Aventis Company Summary
Table 51. Aventis Calcium Channel Antagonist Product Offerings
Table 52. Aventis Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Aventis Key News & Latest Developments
Table 54. Searle Company Summary
Table 55. Searle Calcium Channel Antagonist Product Offerings
Table 56. Searle Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Searle Key News & Latest Developments
Table 58. Bayer Company Summary
Table 59. Bayer Calcium Channel Antagonist Product Offerings
Table 60. Bayer Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Bayer Key News & Latest Developments
Table 62. AstraZeneca Company Summary
Table 63. AstraZeneca Calcium Channel Antagonist Product Offerings
Table 64. AstraZeneca Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. AstraZeneca Key News & Latest Developments
Table 66. Knoll Pharmaceuticals Company Summary
Table 67. Knoll Pharmaceuticals Calcium Channel Antagonist Product Offerings
Table 68. Knoll Pharmaceuticals Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Knoll Pharmaceuticals Key News & Latest Developments
Table 70. Wyeth-Ayerst Company Summary
Table 71. Wyeth-Ayerst Calcium Channel Antagonist Product Offerings
Table 72. Wyeth-Ayerst Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Wyeth-Ayerst Key News & Latest Developments
Table 74. AstraZeneca Company Summary
Table 75. AstraZeneca Calcium Channel Antagonist Product Offerings
Table 76. AstraZeneca Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. AstraZeneca Key News & Latest Developments
Table 78. Novartis Company Summary
Table 79. Novartis Calcium Channel Antagonist Product Offerings
Table 80. Novartis Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Novartis Key News & Latest Developments
Table 82. Sanofi Company Summary
Table 83. Sanofi Calcium Channel Antagonist Product Offerings
Table 84. Sanofi Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Sanofi Key News & Latest Developments
Table 86. Kyowa Kirin Company Summary
Table 87. Kyowa Kirin Calcium Channel Antagonist Product Offerings
Table 88. Kyowa Kirin Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Kyowa Kirin Key News & Latest Developments
Table 90. Daiichi Sankyo Company Summary
Table 91. Daiichi Sankyo Calcium Channel Antagonist Product Offerings
Table 92. Daiichi Sankyo Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Daiichi Sankyo Key News & Latest Developments
Table 94. Shi Huida Company Summary
Table 95. Shi Huida Calcium Channel Antagonist Product Offerings
Table 96. Shi Huida Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Shi Huida Key News & Latest Developments
Table 98. Yangtze River Company Summary
Table 99. Yangtze River Calcium Channel Antagonist Product Offerings
Table 100. Yangtze River Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Yangtze River Key News & Latest Developments
Table 102. Chengdu Bate Company Summary
Table 103. Chengdu Bate Calcium Channel Antagonist Product Offerings
Table 104. Chengdu Bate Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Chengdu Bate Key News & Latest Developments
Table 106. Jiangsu Hengrui Company Summary
Table 107. Jiangsu Hengrui Calcium Channel Antagonist Product Offerings
Table 108. Jiangsu Hengrui Calcium Channel Antagonist Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Jiangsu Hengrui Key News & Latest Developments
Table 110. Calcium Channel Antagonist Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 111. Global Calcium Channel Antagonist Capacity Market Share of Key Manufacturers, 2021-2023
Table 112. Global Calcium Channel Antagonist Production by Region, 2018-2023 (K Units)
Table 113. Global Calcium Channel Antagonist Production by Region, 2024-2029 (K Units)
Table 114. Calcium Channel Antagonist Market Opportunities & Trends in Global Market
Table 115. Calcium Channel Antagonist Market Drivers in Global Market
Table 116. Calcium Channel Antagonist Market Restraints in Global Market
Table 117. Calcium Channel Antagonist Raw Materials
Table 118. Calcium Channel Antagonist Raw Materials Suppliers in Global Market
Table 119. Typical Calcium Channel Antagonist Downstream
Table 120. Calcium Channel Antagonist Downstream Clients in Global Market
Table 121. Calcium Channel Antagonist Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Calcium Channel Antagonist Segment by Type in 2022
Figure 2. Calcium Channel Antagonist Segment by Application in 2022
Figure 3. Global Calcium Channel Antagonist Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Calcium Channel Antagonist Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Calcium Channel Antagonist Revenue, 2018-2029 (US$, Mn)
Figure 7. Calcium Channel Antagonist Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Calcium Channel Antagonist Revenue in 2022
Figure 9. By Type - Global Calcium Channel Antagonist Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Calcium Channel Antagonist Revenue Market Share, 2018-2029
Figure 11. By Type - Global Calcium Channel Antagonist Sales Market Share, 2018-2029
Figure 12. By Type - Global Calcium Channel Antagonist Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Calcium Channel Antagonist Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Calcium Channel Antagonist Revenue Market Share, 2018-2029
Figure 15. By Application - Global Calcium Channel Antagonist Sales Market Share, 2018-2029
Figure 16. By Application - Global Calcium Channel Antagonist Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Calcium Channel Antagonist Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Calcium Channel Antagonist Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Calcium Channel Antagonist Revenue Market Share, 2018-2029
Figure 20. By Region - Global Calcium Channel Antagonist Sales Market Share, 2018-2029
Figure 21. By Country - North America Calcium Channel Antagonist Revenue Market Share, 2018-2029
Figure 22. By Country - North America Calcium Channel Antagonist Sales Market Share, 2018-2029
Figure 23. US Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Calcium Channel Antagonist Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Calcium Channel Antagonist Sales Market Share, 2018-2029
Figure 28. Germany Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 29. France Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Calcium Channel Antagonist Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Calcium Channel Antagonist Sales Market Share, 2018-2029
Figure 37. China Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 41. India Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Calcium Channel Antagonist Revenue Market Share, 2018-2029
Figure 43. By Country - South America Calcium Channel Antagonist Sales Market Share, 2018-2029
Figure 44. Brazil Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Calcium Channel Antagonist Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Calcium Channel Antagonist Sales Market Share, 2018-2029
Figure 48. Turkey Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Calcium Channel Antagonist Revenue, (US$, Mn), 2018-2029
Figure 52. Global Calcium Channel Antagonist Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Calcium Channel Antagonist by Region, 2022 VS 2029
Figure 54. Calcium Channel Antagonist Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 黄体形成ホルモン放出拮抗薬のグローバル市場展望 2023年-2029年：ホルモン療法、免疫療法、標的療法、化学療法、その他
  • 無機カルシウム錠剤のグローバル市場展望 2023年-2029年：炭酸カルシウム、リン酸水素カルシウム、酸化カルシウム、塩化カルシウム、その他
  • 小児用カルシウム錠剤のグローバル市場展望 2023年-2029年：グルコン酸カルシウム、ミルクカルシウム、カゼインカルシウム、その他
  • ベラパミル（カルシウムチャネル遮断薬）のグローバル市場展望 2023年-2029年：錠剤、カプセル
  • 高齢者用カルシウム錠剤のグローバル市場展望 2023年-2029年：液体、錠剤、カプセル
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14253 )"カルシウムチャネル拮抗薬のグローバル市場展望 2023年-2029年：ジヒドロピリジン、非ジヒドロピリジン" (英文：Calcium Channel Antagonist Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。